This needle-free & painless glucose monitoring technology developed by our researchers is applicable for +400 million diabetics and 1,9 billion people who are in a diabetes risk group. #HelsinkiImpact #Slush19 #health #healthtech #diabetes @amchelsinki https://t.co/4tZ3gMYhPD
— University of Helsinki (@helsinkiuni) November 11, 2019 05:47